Rayner Kay Jin Tan, Jane Mingjie Lim, MSW, and Jeremiah Kah Wai Chan, MSc
Merits and drawbacks of U = U messaging are ethically and clinically complex, and drawbacks could harm patients in whom viral suppression is hard to achieve.
AMA J Ethics. 2021;23(5):E418-422. doi:
10.1001/amajethics.2021.418.
E. Berryhill McCarty, MA, MSHCPM and Lance Wahlert, PhD
Global transformation demanded by COVID-19 prompts consideration of how prior epidemics have shaped our cultural and sociological understandings of health care experiences.
AMA J Ethics. 2021;23(5):E423-427. doi:
10.1001/amajethics.2021.423.
John Timothy Kayiwa, MSc, Benard Matovu, MS, Michael Mutebi, Charity Angella Nassuna, MSc, Leonara Nabatanzi, Kevin T. Castle, DVM, MS, Robert M. Kityo, PhD, MS, and Rebekah C. Kading, PhD, MS
Bats are diverse mammals, globally distributed and ecologically critical, yet some carry disease agents that have severe consequences for human health.
AMA J Ethics. 2024;26(2):E153-161. doi:
10.1001/amajethics.2024.153.
High reliability organizations operate in complex, high-hazard domains for extended periods without serious accidents, catastrophic failures, or ecological health threats.
AMA J Ethics. 2024;26(2):E171-178. doi:
10.1001/amajethics.2024.171.
Malaria, HIV and tuberculosis rage as perpetual epidemics in developing nations. Developed nations have an ethical duty and compelling socioeconomic reasons for combatting these global infectious diseases.
Allison Bickford, a science student, discusses multidrug-resistant tuberculosis epidemics in New York and Russia in the 1990s. On the verge of global eradication 20 years ago, TB is now one of the leading infectious causes of death in the world.
Developing drugs for profit is challenged in Parasites!, a patient education comic that highlights the need for unprofitable drugs for tropical diseases.
AMA J Ethics. 2018;20(2):167-175. doi:
10.1001/journalofethics.2018.20.2.msoc1-1802.